Viking Therapeutics, Inc. Debt Instrument, Interest Rate, Stated Percentage
Viking Therapeutics, Inc. (VKTX) had Debt Instrument, Interest Rate, Stated Percentage of 5.00% as of 2016-12-31, per its 10-Q filed 2017-05-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2017-05-10
- 2016-12-31: Debt Instrument, Interest Rate, Stated Percentage 5.00%; Debt Instrument, Interest Rate, Stated Percentage as first filed 2.50%.
- 2016-09-30: Debt Instrument, Interest Rate, Stated Percentage 2.50%.
- 2016-06-30: Debt Instrument, Interest Rate, Stated Percentage 2.50%.
- 2016-03-31: Debt Instrument, Interest Rate, Stated Percentage 2.50%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage | Debt Instrument, Interest Rate, Stated Percentage as first filed |
|---|---|---|
| 2016-12-31 | 5.00% 10-Q · filed 2017-05-10 | 2.50% 10-K · filed 2017-03-21 |
| 2016-09-30 | 2.50% 10-Q · filed 2016-11-10 | |
| 2016-06-30 | 2.50% 10-Q · filed 2016-08-11 | |
| 2016-03-31 | 2.50% 10-Q · filed 2016-05-10 | |
| 2016-01-22 | 2.50% 10-Q · filed 2017-05-10 | |
| 2015-12-31 | 5.00% 10-K · filed 2017-03-21 | |
| 2015-03-31 | 5.00% 10-Q · filed 2016-05-10 | |
| 2014-12-31 | 5.00% 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |